ELISA
LUÑO FERNANDEZ
Investigador/a
University of Innsbruck
Innsbruck, AustriaPublicaciones en colaboración con investigadores/as de University of Innsbruck (7)
2018
-
Clonal architecture in patients with myelodysplastic syndromes and double or minor complex abnormalities: Detailed analysis of clonal composition, involved abnormalities, and prognostic significance
Genes Chromosomes and Cancer, Vol. 57, Núm. 11, pp. 547-556
-
Early platelet count kinetics has prognostic value in lower-risk myelodysplastic syndromes
Blood Advances, Vol. 2, Núm. 16, pp. 2079-2089
-
Health-related quality of life in lower-risk MDS patients compared with age- and sex-matched reference populations: A European LeukemiaNet study
Leukemia, Vol. 32, Núm. 6, pp. 1380-1392
-
Prognostic impact of a suboptimal number of analyzed metaphases in normal karyotype lower-risk MDS
Leukemia Research, Vol. 67, pp. 21-26
2015
-
Validation of the revised international prognostic scoring system (IPSS-R) in patients with lower-risk myelodysplastic syndromes: a report from the prospective European LeukaemiaNet MDS (EUMDS) registry
British Journal of Haematology, Vol. 170, Núm. 3, pp. 372-383
2013
-
Monosomal karyotype in MDS: Explaining the poor prognosis
Leukemia, Vol. 27, Núm. 10, pp. 1988-1995
2012
-
New comprehensive cytogenetic scoring system for primary myelodysplastic syndromes (MDS) and oligoblastic acute myeloid leukemia after MDS derived from an international database merge
Journal of Clinical Oncology, Vol. 30, Núm. 8, pp. 820-829